AMGN compared with APGE: revenue, margins and what each company keeps, and the suppliers and customers both name

AMGNAmgen Inc

Mkt capRevenueRevenue

APGEApogee Therapeutics, Inc.

Mkt capRevenueRevenue

Compare

AMGNAmgen Inc

APGEApogee Therapeutics, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Supply-chain overlap

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only AMGN 12

PODDInsuletsupplier

CYTKCytokineticssupplier

ARWRArrowhead Pharmaceuticalssupplier

LGNDLigand Pharmaceuticalssupplier

8 more · AMGN chain ›

Shared 0

No disclosed counterparties: APGE.

Only APGE 0

None

Role chip = supplier or customerSource: SEC EDGAR

AMGNAmgen Inc

461.49▼−3.55%· post 459.00· delayed

Mkt cap$258.8BRevenue$10.4BQ3 FY26Revenue$36.8BFY25

APGEApogee Therapeutics, Inc.

135.070.00%· post 135.10· delayed

After hoursNov 5 '26delayed

Mkt cap$10.2BRevenue—Revenue—

Compare

After hoursNov 5 '26delayed

AMGNAmgen Inc

APGEApogee Therapeutics, Inc.

461.49▼−3.55%post 459.00delayed

Price

135.070.00%post 135.10delayed

$258.8B

Mkt cap

$10.2B

Q3 FY26$10.4B

Revenue

—

FY25$36.8B

Revenue

—

AMGN461.49▼−3.55%vsAPGE135.070.00%After hoursNov 5 '26delayed